The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development

Gagnier, Joel; Kienle, Gunver S.; Altman, Douglas G.; Moher, David; Sox, Harold C.; Riley, David S.

doi:10.7453/gahmj.2013.008

Cited by 732 publications

(313 citation statements)

References 28 publications

Supporting

Mentioning

269

Contrasting

Unclassified

Order By: Relevance

“…Por último, al final de la discusión es necesario formular conclusiones sobre lo que se obtuvo de este caso, haciendo énfa-sis en el nuevo conocimiento que se generó y en la manera en que este puede ser implementado en la práctica diaria. 7,14 Proponiendo una estandarización: la Guía CARE Existen una variedad de guías propuestas para la elaboración de distintos tipos de estudios: para ensayos clínicos aleatorios, Consolidated Standards of Reporting Trials o CONSORT; 15 Sin embargo, no existía una guía para la elaboración de los reportes de caso, 7,18 hasta 2013, cuando el grupo CARE (CAse REport) publicó "Las Guías CARE: desarrollo basado en el consenso de pautas para informes de casos clínicos". 4 En esta guía se proponen los siguientes 13 pasos para la construcción de un reporte de un caso clínico o una serie de casos:…”

Section: Reporte De Caso Clínico: Descripción Y Componentesunclassified

“…En términos generales, en estos documentos se narran, entre otras cosas, el descubrimiento de nuevas enfermedades, la presentación de enfermedades raras, formas inusuales de enfermedades comunes, las complicaciones de un tratamiento común, o bien, el efecto (benéfico o adverso) de un tratamiento habitual o no de enfermedades comunes. 7,8 Es conveniente distinguir que, el o los reportes de caso son un tipo de publicación que hace una descripción detallada sobre un paciente en particular, mientras que la serie de casos es un artículo que describe a un conjunto de pacientes con una o más características en común, lo que permite incluirlos dentro de un mismo grupo. 4,5 El número de sujetos en los reportes de casos (también llamados serie de casos) generalmente no deberá ser mayor de 10 a 12; cuando se excede esta cifra se recomienda utilizar otro tipo de diseño de investigación específico, como cohorte (cuando sea eminentemente descriptivo y observacional) o estudio cuasiexperimental (cuando se trata de mostrar los cambios por el uso de alguna intervención).…”

Section: Introductionunclassified

See 1 more Smart Citation

La importancia de los reportes de casos clínicos en la investigación

Pineda-Leguízamo

Miranda-Novales

Villasís‐Keever

2018

RAM

View full text Add to dashboard Cite

Este artículo debe citarse como: Pineda-Leguízamo R, Miranda-Novales G, Villasís-Keever MA. La importancia de los reportes de casos clínicos en la investigación. Rev Alerg Mex. 2018;65(1):92-98 ORCID Ricardo Pineda-Leguízamo, 0000-0002-7330-0907; Guadalupe Miranda-Novales, 0000-0003-3262-2608; Miguel Ángel Villasís-Keever, 0000-0002-8566-0811 AbstractClinical case reports correspond to articles that have the lowest level of evidence within different research trials. However, not only are they common and significant in the medical field, but they have often been the basis the generation of research. The purpose of their publication can be scientific or educational. In general terms, the discovery of new diseases, the presentation of rare diseases, unusual forms of common diseases, the complications of a common treatment, or the effect (beneficial or adverse) of a treatment, among other things, are narrated in these documents. Clinical case reports continue to be one of the most important sources of knowledge. The advent of a standardized guideline for the creation of this type of reports allows homogenizing the form and content of the cases intended to be described in the near future and, furthermore, will enable authors to have a reference when preparing this type of publications. Case reports are valuable resources of new and unusual information that can encourage and serve to conduct future research studies with a higher level of evidence.

show abstract

Section: Reporte De Caso Clínico: Descripción Y Componentesunclassified

Section: Introductionunclassified

La importancia de los reportes de casos clínicos en la investigación

Pineda-Leguízamo

Miranda-Novales

Villasís‐Keever

2018

RAM

View full text Add to dashboard Cite

show abstract

“…This report follows adaptations of the CARE Guidelines [13] for therapeutic massage and bodywork publications [14]. Informed consent was obtained from the patient, the persons starring in the demo videos, and all individuals mentioned in the acknowledgements.…”

Section: Methodsmentioning

confidence: 99%

Passive Hydrotherapy WATSU® for Rehabilitation of an Accident Survivor: A Prospective Case Report

Schitter

Fleckenstein

2018

Complement Med Res

View full text Add to dashboard Cite

Background: WaterShiatsu (WATSU) is a passive form of hydrotherapy in warm water (35 °C) that aims at relaxation, pain relief, and a sense of security. This case report focuses on a patient's experience of integrating WATSU into her rehabilitative care. Case Report: A 52-year-old woman survived a severe motorcycle accident in which she sustained several fractures on the right side of her body, including ribs, the pelvis, and the femur. After discharge from stationary care, she independently scheduled 8 weekly WATSU sessions with an experienced WATSU therapist also trained in physiotherapy and psychosomatics. Quantitative and qualitative data obtained from the patient's diary and the therapist's notes is presented. Results: The patient associated WATSU with physical and emotional release, reconciliation with her body, and trunk mobilization (followed by ameliorated breath). She ascribed WATSU lasting effects on her body image and reported continuous improvement by the Patient-Specific Functional Scale. The therapist employed WATSU to equalize awareness throughout the body and for careful mobilization. Due to complications (elevated inflammation markers), only 6 of 8 scheduled sessions were administered. Conclusions: WATSU was experienced as helpful in approaching a condition that the patient felt insufficiently covered by conventional physiotherapy alone. In early rehabilitation, additional medical/physiotherapeutic skills of contributing complementary therapists are advocated.

show abstract

“…To corroborate such data, observational studies were searched, identi- fying only six case reports that included cases of addiction and psychotic disorders. Case report studies often describe unpublished or unknown outcomes of a given treatment (53).…”

Section: Relevance For Decision Makingmentioning

confidence: 99%

Systematic Review and Meta-Analysis of The Efficacy And Safety Of Amfepramone and Mazindol As A Monotherapy for The Treatment of Obese or Overweight Patients

et al. 2017

View full text Add to dashboard Cite

The aim of this study was to evaluate efficacy and safety of amfepramone, fenproporex and mazindol as a monotherapy for the treatment of obese or overweight patients. A systematic review of primary studies was conducted, followed by a direct meta-analysis (random effect) and mixed treatment comparison. Medline and other databases were searched. Heterogeneity was explored through I 2 associated with a p-value. Of 739 identified publications, 25 were included in the meta-analysis. The global evaluation of Cochrane resulted in 19 studies with a high level of bias and six with unclear risk. Due to the lack of information in primary studies, direct meta-analyses were conducted only for amfepramone and mazindol. Compared to placebo, amfepramone resulted in higher weight loss in the short-term (o180 days; mean difference (MD) -1.281 kg; po0.05; I 2 : 0.0%; p=0.379) and long-term (X180 days; MD -6.518 kg; po0.05; I 2 : 0.0%; p=0.719). Only studies with long-term follow up reported efficacy in terms of abdominal circumference and 5-10% weight reduction. These results corroborated the finding that the efficacy of amfepramone is greater than that of placebo. Treatment with mazindol showed greater short-term weight loss than that with placebo (MD -1.721 kg; po0.05; I 2 : 0.9%; p=0.388). However, metabolic outcomes were poorly described, preventing a meta-analysis. A mixed treatment comparison corroborated the direct meta-analysis. Considering the high level of risk of bias and the absence of important published outcomes for anti-obesity therapy assessments, this study found that the evaluated drugs showed poor evidence of efficacy in the treatment of overweight and obese patients. Robust safety data were not identified to suggest changes in their regulatory status.

show abstract

The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development

Cited by 732 publications

References 28 publications

La importancia de los reportes de casos clínicos en la investigación

La importancia de los reportes de casos clínicos en la investigación

Passive Hydrotherapy WATSU® for Rehabilitation of an Accident Survivor: A Prospective Case Report

Systematic Review and Meta-Analysis of The Efficacy And Safety Of Amfepramone and Mazindol As A Monotherapy for The Treatment of Obese or Overweight Patients

Contact Info

Product

Resources

About